Ceribell CFO to Present at Canaccord Genuity Forum
Sunnyvale-based Ceribell CFO Scott Blumberg will speak at an industry forum in New York City on November 11, 2026.
Updated on Oct. 28, 2026 in Healthcare
Ceribell Chief Financial Officer Scott Blumberg is scheduled to participate in a fireside chat at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 11, 2026. The executive from the Sunnyvale company will discuss operations at the event.
Why it matters
The forum provides a venue for the medical technology firm to communicate with investors and stakeholders about its business and clinical goals. This participation highlights the company's efforts to maintain transparency and provide updates to the investment community.
The fireside chat is set to occur on November 11, 2026, at 7:00 a.m. PST, which corresponds to 10:00 a.m. EST. Ceribell currently operates as a medical technology company based in Sunnyvale, California.
The players
Scott Blumberg
Scott Blumberg serves as the Chief Financial Officer for the medical technology company Ceribell.
Ceribell
Ceribell is a Sunnyvale, California-based medical technology company focused on FDA-cleared devices for seizure detection and delirium monitoring.
The details
The event focuses on MedTech, diagnostics, and digital health services where Ceribell will showcase its system. The Ceribell System is currently FDA-cleared for the detection of seizures and monitoring delirium in emergency rooms and intensive care units.
Timeline
The fireside chat with Scott Blumberg is scheduled for November 11, 2026.
Market Landscape
This participation at the Canaccord Genuity forum reflects a broader trend of MedTech firms engaging directly with capital markets to distinguish their diagnostic innovations. The company is positioning its FDA-cleared technology against established monitoring solutions within a highly competitive health landscape.
For investors and clients, this presentation offers a chance to gain insight into the company's financial health and strategic direction. Interested parties can track the company's performance by accessing the webcast provided on their investor portal.
The takeaway
Engagement at major investment forums allows medical technology companies to clearly communicate the clinical value of their FDA-cleared devices. Investors should monitor these presentations for potential updates regarding operational milestones and market expansion plans.
What happens next
The company will provide a live and archived webcast of the fireside chat on November 11, 2026, through its investor relations website.
Further reading
Learn more about the latest innovations and corporate news in the Healthcare sector.
More information
View the webcast or access company documents at the Ceribell investor relations webcast portal.
Source note: This article includes information reported by The Manila times.
